Cargando…
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway
BACKGROUND: The antiangiogenic agent cilengitide disrupts integrin binding to the extracellular matrix leading to apoptosis of activated endothelial cells. Integrins are also widely expressed in malignant glioma and integrin inhibitors may directly target tumor cells in this disease. Aim of the curr...
Autores principales: | Oliveira-Ferrer, Leticia, Hauschild, Jessica, Fiedler, Walter, Bokemeyer, Carsten, Nippgen, Johannes, Celik, Ilhan, Schuch, Gunter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648308/ https://www.ncbi.nlm.nih.gov/pubmed/19114005 http://dx.doi.org/10.1186/1756-9966-27-86 |
Ejemplares similares
-
Cilengitide inhibits osteoclast adhesion through blocking the α(v)β(3)-mediated FAK/Src signaling pathway
por: Guo, Dan-yang, et al.
Publicado: (2023) -
Gene expression profiling of the anti-glioma effect of Cilengitide
por: Onishi, Manabu, et al.
Publicado: (2013) -
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2013) -
PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway
por: Dong, Caihua, et al.
Publicado: (2021) -
In vitro and in vivo drug disposition of cilengitide in animals and human
por: Dolgos, Hugues, et al.
Publicado: (2016)